Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Pyott David E I
Over the trailing 90 days, Pyott David E I (Director at ALNYLAM PHARMACEUTICALS, INC.) sold $1.1M of stock across 2 companies, per 12 SEC Form 4 transactions.
- Role
- Director
- Window
- Trailing 90 days · 12 transactions · CIK 1051578
- Net activity
- −$1.1M ($0 bought · $1.1M sold)
By Company (Trailing 90 Days)
Transactions (12)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-06-25 | TARS | Buy | 3.8K | $0 | Grant, award or other acquisition |
| 2026-06-25 | TARS | Buy | 806 | $0 | Grant, award or other acquisition |
| 2026-06-25 | TARS | Buy | 2.4K | $0 | Grant, award or other acquisition |
| 2026-06-01 | ALNY | Sell | 495 | $149K | Open market or private sale |
| 2026-06-01 | ALNY | Sell | 17 | $5K | Open market or private sale |
| 2026-06-01 | ALNY | Sell | 3.8K | $0 | Exercise or conversion of derivative security |
| 2026-06-01 | ALNY | Sell | 1.2K | $366K | Open market or private sale |
| 2026-06-01 | ALNY | Sell | 1.2K | $351K | Open market or private sale |
| 2026-06-01 | ALNY | Sell | 921 | $274K | Open market or private sale |
| 2026-06-01 | ALNY | Buy | 3.8K | $0 | Exercise or conversion of derivative security |
| 2026-05-20 | ALNY | Buy | 1.4K | $0 | Grant, award or other acquisition |
| 2026-05-20 | ALNY | Buy | 671 | $0 | Grant, award or other acquisition |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Pyott's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.